A Study on the comparison of two unani formulations in the management of White patches.

A Single-Blind Randomized Clinical trial of Unani formulations in the treatment of Bahaq (Pityriasis). - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093823

Enrollment

Registered

2025-08-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L819- Disorder of pigmentation, unspecified

Interventions

Intervention1: Test Drug- Turmus (Lupinus albus) and Roghan Bedanjeer (Castor oil) Ricinus communis : Turmus (Lupinus albus), commonly known as white lupin or lupine, is a leguminous plant. Root of Tu

Eligibility

Inclusion criteria

Inclusion criteria: 1. Includes all gender with age 03 years and above (School going children). 2. Diagnosed cases of Bahaq over hands, legs, neck and face. 3. Patients who agreed to sign the consent form.

Exclusion criteria

Exclusion criteria: 1.All gender patients below 03 years. 2.Patients with other concomitant skin diseases. 3.Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Improvement in sign and symptoms- Hypopigmentation, scaling and itching.Timepoint: 3 weeks	—

Secondary

Measure	Time frame
Changes in the condition on the basis of photographsTimepoint: 0, 14th and 21st day	—

Countries

India

Contacts

Public ContactMohd Riyaz Alam

Ajmal Khan Tibbiya College

drzamiramrohi@gmail.com8475007594

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026